Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hypertension

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 66 articles:
HTML format
Text format



Single Articles


    May 2018
  1. BLANKESTIJN PJ, Bots ML
    Renal denervation in uncontrolled hypertension: the story continues to unfold.
    Lancet. 2018 May 22. pii: S0140-6736(18)31112.
    PubMed     Text format    


  2. AZIZI M, Schmieder RE, Mahfoud F, Weber MA, et al
    Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.
    Lancet. 2018 May 22. pii: S0140-6736(18)31082.
    PubMed     Text format     Abstract available


  3. KANDZARI DE, Bohm M, Mahfoud F, Townsend RR, et al
    Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.
    Lancet. 2018 May 22. pii: S0140-6736(18)30951.
    PubMed     Text format     Abstract available


    February 2018
  4. RIETZSCHEL ER, De Buyzere ML
    Hypertension: time for doctors to switch the driver's seat?
    Lancet. 2018 Feb 27. pii: S0140-6736(18)30317.
    PubMed     Text format    


  5. MCMANUS RJ, Mant J, Franssen M, Nickless A, et al
    Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial.
    Lancet. 2018 Feb 27. pii: S0140-6736(18)30309.
    PubMed     Text format     Abstract available


    January 2018
  6. CHAKER L, Bianco AC, Jonklaas J, Peeters RP, et al
    Hypothyroidism and hypertension: fact or myth? - Authors' reply.
    Lancet. 2018;391:30.
    PubMed     Text format    


  7. HOFSTETTER L, Messerli FH
    Hypothyroidism and hypertension: fact or myth?
    Lancet. 2018;391:29-30.
    PubMed     Text format    


    October 2017
  8. SU M, Zhang Q, Bai X, Wu C, et al
    Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey.
    Lancet. 2017 Oct 25. pii: S0140-6736(17)32476.
    PubMed     Text format     Abstract available


  9. HESKETH T, Zhou X
    Hypertension in China: the gap between policy and practice.
    Lancet. 2017 Oct 25. pii: S0140-6736(17)32743.
    PubMed     Text format    


  10. LU J, Lu Y, Wang X, Li X, et al
    Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project).
    Lancet. 2017 Oct 25. pii: S0140-6736(17)32478.
    PubMed     Text format     Abstract available


    September 2017
  11. SPIERING W, Williams B, Van der Heyden J, van Kleef M, et al
    Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study.
    Lancet. 2017 Sep 1. pii: S0140-6736(17)32337.
    PubMed     Text format     Abstract available


  12. COURAND PY, Lantelme P
    Stretching the carotid sinus to treat resistant hypertension.
    Lancet. 2017 Sep 1. pii: S0140-6736(17)32298.
    PubMed     Text format    


    August 2017
  13. AZIZI M
    Catheter-based renal denervation for treatment of hypertension.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32293.
    PubMed     Text format    


  14. TOWNSEND RR, Mahfoud F, Kandzari DE, Kario K, et al
    Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32281.
    PubMed     Text format     Abstract available


    July 2017
  15. RODGERS A, Chow CK, Thakkar J, Bennett A, et al
    A personalised or procrustean approach to treating hypertension? - Authors' reply.
    Lancet. 2017;390:27-28.
    PubMed     Text format    


  16. GABB GM, Mol PGM, Arnolda LF
    A personalised or procrustean approach to treating hypertension?
    Lancet. 2017;390:26-27.
    PubMed     Text format    


    June 2017
  17. MUNDLE S, Bracken H, Khedikar V, Mulik J, et al
    Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trial.
    Lancet. 2017 Jun 28. pii: S0140-6736(17)31367.
    PubMed     Text format     Abstract available


  18. SURI V, Sikka P
    Oral misoprostol for induction of labour in hypertensive pregnancies.
    Lancet. 2017 Jun 28. pii: S0140-6736(17)31453.
    PubMed     Text format    


    April 2017
  19. VIDAL-PETIOT E, Bhatt DL, Fox KM, Steg PG, et al
    Blood pressure and cardiovascular outcomes: a closer look - Authors' reply.
    Lancet. 2017;389:1296-1297.
    PubMed     Text format    


  20. WALD NJ, Wald DS
    Blood pressure and cardiovascular outcomes: a closer look.
    Lancet. 2017;389:1296.
    PubMed     Text format    


  21. DOUMAS M, Stavropoulos KV, Boutari C, Imprialos KP, et al
    Blood pressure and cardiovascular outcomes: a closer look.
    Lancet. 2017;389:1295-1296.
    PubMed     Text format    


    March 2017
  22. LUYCKX VA, Perico N, Somaschini M, Manfellotto D, et al
    A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group.
    Lancet. 2017 Mar 8. pii: S0140-6736(17)30576.
    PubMed     Text format    


    February 2017
  23. GRADMAN AH
    A quarter-dose quadpill for initial treatment of hypertension.
    Lancet. 2017 Feb 9. pii: S0140-6736(17)30331.
    PubMed     Text format    


  24. CHOW CK, Thakkar J, Bennett A, Hillis G, et al
    Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.
    Lancet. 2017 Feb 9. pii: S0140-6736(17)30260.
    PubMed     Text format     Abstract available


    January 2017
  25. BLACHER J, Levy BI, Mourad JJ, Safar ME, et al
    Hypertension control and cardiovascular disease - Authors' reply.
    Lancet. 2017;389:154-155.
    PubMed     Text format    


  26. JAMES JE
    Hypertension control and cardiovascular disease.
    Lancet. 2017;389:154.
    PubMed     Text format    


  27. MESSERLI FH, Fischer U, Rimoldi SF, Bangalore S, et al
    Hypertension control and cardiovascular disease.
    Lancet. 2017;389:153.
    PubMed     Text format    


  28. ZENG X, Deng A, Ding Y
    The INTERSTROKE study on risk factors for stroke.
    Lancet. 2017;389:35.
    PubMed     Text format    


    December 2016
  29. SLIWA K
    The heart of Africa: succeeding against the odds.
    Lancet. 2016;388:e28-e36.
    PubMed     Text format     Abstract available


    October 2016
  30. SCHOFIELD G, Henderson G, Crofts C
    Beyond salt-where next for hypertension epidemiology?
    Lancet. 2016;388:2110-2111.
    PubMed     Text format    


  31. MENTE A, O'Donnell MJ, Yusuf S
    Sodium and cardiovascular disease - Authors' reply.
    Lancet. 2016;388:2113-2114.
    PubMed     Text format    


  32. CAPPUCCIO FP
    Sodium and cardiovascular disease.
    Lancet. 2016;388:2112.
    PubMed     Text format    


  33. KATZ J
    Sodium and cardiovascular disease.
    Lancet. 2016;388:2112-2113.
    PubMed     Text format    


  34. STRAZZULLO P, Giampaoli S, Iacoviello L, Rossi L, et al
    Sodium and cardiovascular disease.
    Lancet. 2016;388:2111.
    PubMed     Text format    


  35. WALD N, Law M
    Sodium and cardiovascular disease.
    Lancet. 2016;388:2111-2112.
    PubMed     Text format    


  36. ALDERMAN MH
    Dietary sodium: paradigm shifts from public health to clinical medicine.
    Lancet. 2016;388:2110.
    PubMed     Text format    



  37. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1659-1724.
    PubMed     Text format     Abstract available


    September 2016
  38. WATTS G
    Neil Poulter: upping the pressure on hypertension.
    Lancet. 2016 Sep 29. pii: S0140-6736(16)31775.
    PubMed     Text format    


  39. OLSEN MH, Angell SY, Asma S, Boutouyrie P, et al
    A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension.
    Lancet. 2016 Sep 22. pii: S0140-6736(16)31134.
    PubMed     Text format    


    August 2016
  40. MANCIA G
    Should blood pressure reduction be aggressive in patients with hypertension and coronary artery disease?
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31398.
    PubMed     Text format    


  41. VIDAL-PETIOT E, Ford I, Greenlaw N, Ferrari R, et al
    Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31326.
    PubMed     Text format     Abstract available


  42. WALLENTIN L, Lindhagen L, Arnstrom E, Husted S, et al
    Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study.
    Lancet. 2016 Aug 25. pii: S0140-6736(16)31276.
    PubMed     Text format     Abstract available


    July 2016
  43. KAIN K
    Blood pressure lowering for cardiovascular disease.
    Lancet. 2016;388:126.
    PubMed     Text format    


  44. ETTEHAD D, Emdin CA, Kiran A, Rahimi K, et al
    Blood pressure lowering for cardiovascular disease - Authors' reply.
    Lancet. 2016;388:126-7.
    PubMed     Text format    


  45. O'KEEFFE DT, Maraka S
    Blood pressure lowering for cardiovascular disease.
    Lancet. 2016;388:125.
    PubMed     Text format    


  46. SMULDERS YM, Muller M
    Blood pressure lowering for cardiovascular disease.
    Lancet. 2016;388:125-6.
    PubMed     Text format    


  47. COLLINS DR, Albasri A, O'Sullivan J, Bobrovitz N, et al
    Blood pressure lowering for cardiovascular disease.
    Lancet. 2016;388:125.
    PubMed     Text format    


    June 2016
  48. SONODA Y, Higuchi A, Morita T, Mori J, et al
    Intensive blood pressure lowering.
    Lancet. 2016;387:2291.
    PubMed     Text format    


  49. XIE X, Atkins E, Lv J, Rodgers A, et al
    Intensive blood pressure lowering - Authors' reply.
    Lancet. 2016;387:2291.
    PubMed     Text format    


    May 2016
  50. OK E, Asci G, Chazot C, Ozkahya M, et al
    Controversies and problems of volume control and hypertension in haemodialysis.
    Lancet. 2016 May 20. pii: S0140-6736(16)30389.
    PubMed     Text format     Abstract available


  51. MENTE A, O'Donnell M, Rangarajan S, Dagenais G, et al
    Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies.
    Lancet. 2016 May 20. pii: S0140-6736(16)30467.
    PubMed     Text format     Abstract available


    April 2016
  52. WILLIAMS B, MacDonald TM, Morant SV, Brown MJ, et al
    PATHWAY-2: spironolactone for resistant hypertension - Authors' reply.
    Lancet. 2016;387:1373-4.
    PubMed     Text format    


  53. DALE A, Hartley P, Goldacre B
    PATHWAY-2: spironolactone for resistant hypertension.
    Lancet. 2016;387:1372-3.
    PubMed     Text format    


  54. GKALIAGKOUSI E, Gavriilaki E, Triantafyllou A, Douma S, et al
    PATHWAY-2: spironolactone for resistant hypertension.
    Lancet. 2016;387:1372.
    PubMed     Text format    


  55. BOUTARI C, Stavropoulos K, Imprialos K, Doumas M, et al
    PATHWAY-2: spironolactone for resistant hypertension.
    Lancet. 2016;387:1371-2.
    PubMed     Text format    


  56. ZALCMAN G, Mazieres J, Margery J, Greillier L, et al
    Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.
    Lancet. 2016;387:1405-14.
    PubMed     Text format     Abstract available


    March 2016
  57. LAURENT S, Boutouyrie P
    Blood pressure lowering trials: wrapping up the topic?
    Lancet. 2016;387:923-4.
    PubMed     Text format    


    February 2016
  58. BLACHER J, Levy BI, Mourad JJ, Safar ME, et al
    From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century.
    Lancet. 2016 Feb 5. pii: S0140-6736(16)00002.
    PubMed     Text format    


    January 2016
  59. BRUNSTROM M, Carlberg B
    Lower blood pressure targets: to whom do they apply?
    Lancet. 2016;387:405-6.
    PubMed     Text format    


    December 2015
  60. ETTEHAD D, Emdin CA, Kiran A, Anderson SG, et al
    Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
    Lancet. 2015 Dec 23. pii: S0140-6736(15)01225.
    PubMed     Text format     Abstract available



  61. Health security: the defining challenge of 2016.
    Lancet. 2015;386:2445.
    PubMed     Text format    


    November 2015
  62. LOBO MD, Sobotka PA, Dolan E, Witkowski A, et al
    Central arteriovenous anastomosis and hypertension - Authors' reply.
    Lancet. 2015;386:1821-2.
    PubMed     Text format    


  63. DEINUM J, Wetzels JF
    Central arteriovenous anastomosis and hypertension.
    Lancet. 2015;386:1821.
    PubMed     Text format    


  64. XIE X, Atkins E, Lv J, Bennett A, et al
    Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
    Lancet. 2015 Nov 7. pii: S0140-6736(15)00805.
    PubMed     Text format     Abstract available


    October 2015
  65. BROEKHUIJSEN K, Groen H, van den Berg PP, Mol BW, et al
    Gestational hypertension and advanced maternal age - Authors' reply.
    Lancet. 2015;386:1628.
    PubMed     Text format    


  66. DIETL A, Farthmann J
    Gestational hypertension and advanced maternal age.
    Lancet. 2015;386:1627-8.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: